Analyzing RNA data to improve cancer treatment
Specialized RNA analysis center for integrative genomic analyses
['FUNDING_OTHER'] · UNIV OF NORTH CAROLINA CHAPEL HILL · NIH-10913350
This study is looking at how genes behave in cancer to help doctors find the best treatments for patients by understanding the different types of cancer better, so you can get care that's just right for you.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIV OF NORTH CAROLINA CHAPEL HILL (nih funded) |
| Locations | 1 site (CHAPEL HILL, UNITED STATES) |
| Trial ID | NIH-10913350 on ClinicalTrials.gov |
What this research studies
This research focuses on analyzing RNA expression data to enhance our understanding of cancer genomics and improve precision medicine. By integrating RNA data with other genomic information, the project aims to identify specific molecular subtypes of cancer that can inform clinical decisions. The research will utilize advanced techniques in RNA sequencing and spatial genomics to analyze clinical trial samples, ultimately aiming to improve cancer classification and patient outcomes. Patients may benefit from more tailored treatment options based on their unique cancer profiles.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with various types of cancer who are participating in clinical trials.
Not a fit: Patients with non-cancerous conditions or those not involved in clinical trials may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective cancer treatments for patients.
How similar studies have performed: Previous research initiatives, such as The Cancer Genome Atlas, have shown success in utilizing genomic data to improve cancer treatment strategies.
Where this research is happening
CHAPEL HILL, UNITED STATES
- UNIV OF NORTH CAROLINA CHAPEL HILL — CHAPEL HILL, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: HOADLEY, KATHERINE A. — UNIV OF NORTH CAROLINA CHAPEL HILL
- Study coordinator: HOADLEY, KATHERINE A.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: American Association of Cancer Research